3 ms·
If the promise of in silico drug design comes to fruition, the potential drug discovery profits could very well rival Google's ad profits.
by folli 5y ago
If the promise of in silico drug design comes to fruition, the potential drug discovery profits could very well rival Google's ad profits.
- dekhn 5y agoSure. AlphaFold is, in fact, the greatest shot at revenue that DeepMind has shown so far (and they are under intense pressure from Alphabet to show revenue).
- alphabetting 5y agoI don't think there is any pressure on that front. They are supposedly profitable now (though i'm guessing this is partially accounting tricks) but there just isn't a need to be profitable. Search and Youtube print money to fund their R&D ($31B last year alone). The goal is AGI or close to it. https://venturebeat.com/2021/10/10/ai-lab-deepmind-becomes-profitable-and-bolsters-relationship-with-google/ https://venturebeat.com/2021/10/10/ai-lab-deepmind-becomes-p...
- dekhn 5y agoThe "profit" you're pointing at is money that Google pays DeepMind to do software and machine learning as a service for them. This pays off, for example with Jax, where nobody in Google Research could touch it because Jeff Dean/Tensorflow, until DM demonstrated (with alphafold) that Jax could do nobel-prize-winning research, to the point where Jeff has admitted that tensorflow has serious problems and systems like jax are the future (see the palm paper!!!)